The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-A farewell to bulls? Regional, local leaders disagree on Spain's Pamplona festival

Tue, 02nd Feb 2021 13:11

(Recasts with Pamplona mayor, Madrid regional leader, Brazil)

MADRID, Feb 2 (Reuters) - Spain's San Fermin festival, which
attracts tourists from all over the world for the running of the
bulls through the streets of Pamplona, will be cancelled for the
second year in a row because of COVID-19, the regional head said
on Tuesday.

But amid much disagreement and handwringing across Spain
over how strict pandemic restrictions should be, Pamplona's
mayor was quick to say no decision had yet been made.

"An international festival like San Fermin, in which
millions of people come to Navarra, won't be possible," Maria
Chivite, president of Navarra's regional administration, said.

The local Diario de Navarra newspaper quoted Pamplona Mayor
Enrique Maya as saying: "All citizens are aware that, with the
available data, it will obviously be difficult to talk about
(the festival) as we have known it until now, but today on Feb.2
... there's no decision made."

In a country where COVID restrictions vary from region to
region, and sometimes city to city, such disagreement over
restrictions are rife.

Madrid region's conservative leader, Isabel Diaz Ayuso,
defended on Tuesday her decision to relax some restrictions in
the capital, saying she had not seen any scientific evidence
that meals in restaurants were more contagious than gatherings
at home.

"Health is many things, not just avoiding infection," she
said.

From Friday, groups of up to six will be allowed to gather
in outdoor restaurant terraces in the Madrid region, up from
four now. A 10 p.m. curfew might be pushed to midnight in
Madrid, where people are still allowed to eat and drink inside
bars and restaurants, while theatres and museums remain open.

Ayuso has often clashed with the left-wing central
government on how to tackle the COVID-19 crisis.

"In the fight against the pandemic there are no shortcuts...
It's not advisable or reasonable to start hurrying to wind down
(the restrictions)," government spokeswoman Maria Jesus Montero
told a news conference.

The Spanish government decided on Tuesday to restrict air
travel with Brazil and South Africa, where new highly contagious
variants of the coronavirus have been detected.

Inbound flights will only be able to carry Spanish nationals
and residents returning to Spain or transit passengers traveling
to countries outside of the Schengen Area with stopovers shorter
than 24 hours, it said.

The health ministry will decide this week whether or not to
give AstraZeneca's recently approved COVID-19 vaccine to
elderly people.

Several European countries including Germany, Poland and
Austria have restricted the shot to younger people amid a lack
of clinical data on its use in people over 65.

On Monday, Spain reported 79,686 new cases since Friday,
slowing from the previous weekend's tally of 93,822 and pushing
the cumulative total above 2.8 million. The death toll rose by
762 to 59,081.
(Reporting by Inti Landauro, Nathan Allen, Belen Carreno
Writing by Nathan Allen
Editing by Ingrid Melander and Angus MacSwan)

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.